Registration:Feb 9, 2001
Status:710 - Cancelled - section 8
Status date:Nov 28, 2014
Illustration:Drawing or design which also includes word(s)/ letter(s)/number(s)
Attorney:Michael W. Garvey
Pearne & Gordon LLP
Suite 1200, Cleveland, OH 44114
Employee:John T Lincoski
Goods & Services:In the statement column 1 line 8, "immuno comprised" should be deleted, and "immunocomprised" should be inserted., "orphan", The design is a globe., Pharmaceuticals for the treatment of rare diseases, namely, in the field of cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, pallative care, poison control, respiratory diseases, urology and psychiatric diseases, Product research and development of...
Owners (3):Swedish Orphan International Ab, Drottninggatan 98, Stockholm, Sweden
Orphan Pharmaceuticals-Usa, Inc, 1101 Kermit Drive Suite 608, Nashville, TN 37217 >
Orphan Pharmaceuticals, U.s.a., Inc, 1101 Kermit Dr., Ste 608, Nashville, TN 37217 >
Reviews Write Review
No reviews for ORPHAN yet.